1. Midazolam attenuates ketamine-induced abnormal perception and thought process but not mood changes
- Author
-
Peter S. Lansing, Rachel A. Sheppard, Merritt M. Tolan, Kentaro Tsueda, Manzo Suzuki, Thomas M. Fuhrman, Harrell E. Hurst, and Steven Lippmann
- Subjects
Adult ,Male ,genetic structures ,Visual analogue scale ,medicine.drug_class ,Midazolam ,Sedation ,Blood Pressure ,Neuropsychological Tests ,Thinking ,Hypnotic ,Double-Blind Method ,Heart Rate ,medicine ,Humans ,Ketamine ,Anesthetics, Dissociative ,business.industry ,General Medicine ,Middle Aged ,Affect ,Anesthesiology and Pain Medicine ,Mood ,Anti-Anxiety Agents ,Sedative ,Anesthesia ,NMDA receptor ,Perception ,Sleep Stages ,medicine.symptom ,Cognition Disorders ,business ,Psychomotor Performance ,medicine.drug - Abstract
Purpose: To determine the effects of midazolam, 30 ng·mL−1, on altered perception, mood, and cognition induced by ketamine. Methods: After ketamine was administered to achieve target concentrations of 50, 100, or 150 ng·mL−1 in 11 volunteers, perception, mood, and thought process were assessed by a visual analog scale. Mini-Mental State examination (MMSE) assessed cognition. Boluses of midazolam, 30, 14.5, and 12µg·kg−1, were injected every 30 min to maintain the plasma concentration at 30 ng·mL−1, which was reached 30 min after each injection. Results: Ketamine produced changes in perception about the body (P
- Published
- 2000
- Full Text
- View/download PDF